The fact that patients with presumed local disease at DCE-MRI have a better prognosis after local treatment than patients without it supports the hypothesis that the lack of a visible though unproven local source of PSA production is associated with a higher risk of micrometastatic disease elsewhere, regionally and/or distantly, at the time of sRT. Here, KLK3 is linked to glycogen storage disease VI.